Hepatic veno-occlusive disease after hemopoietic stem cell transplantation.

被引：0
|
作者：
Da, WM [1 ]
Zhong, JT [1 ]
Liu, Y [1 ]
机构：
[1] PLA,LANZHOU INST HEMATOL,LANZHOU 730050,PEOPLES R CHINA
来源：
EXPERIMENTAL HEMATOLOGY | 1996年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：595 / 595
页数：1
相关论文
共 50 条
  • [21] Hepatic veno-occlusive disease after tandem autologous stem cell transplantation conditioned by melphalan
    Sana Intidhar Labidi
    Catherine Sebban
    Hervé Ghesquières
    Emmanuele Virelizier Nicolas
    Pierre Biron
    International Journal of Hematology, 2008, 88 : 291 - 293
  • [22] Hepatic veno-occlusive disease after tandem autologous stem cell transplantation conditioned by melphalan
    Labidi, Sana Intidhar
    Sebban, Catherine
    Ghesquieres, Herve
    Nicolas, Emmanuele Virelizier
    Biron, Pierre
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (03) : 291 - 293
  • [23] Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation
    Corbacioglu, Selim
    Kernan, Nancy
    Lehmann, Leslie
    Brochstein, Joel
    Revta, Carolyn
    Grupp, Stephan
    Martin, Paul
    Richardson, Paul G.
    EXPERT REVIEW OF HEMATOLOGY, 2012, 5 (03) : 291 - 302
  • [24] Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation
    Hamada, Takashi
    Takahashi, Hiromichi
    Nakagawa, Masaru
    Nukariya, Hironao
    Ito, Shun
    Endo, Toshihide
    Kurihara, Kazuya
    Koike, Takashi
    Iizuka, Kazuhide
    Ohtake, Shimon
    Ichinohe, Takashi
    Maebayashi, Toshiya
    Miura, Katsuhiro
    Hatta, Yoshihiro
    Nakamura, Hideki
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 353 - 361
  • [25] N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation
    O Ringdén
    M Remberger
    S Lehmann
    P Hentschke
    J Mattsson
    S Klaesson
    J Aschan
    Bone Marrow Transplantation, 2000, 25 : 993 - 996
  • [26] Incidence and predictive factors of hepatic veno-occlusive disease after bone marrow transplantation.
    Deliliers, GL
    Della Volpe, A
    Bamonti, F
    Deliliers, DL
    Onida, F
    Annaloro, C
    Soligo, D
    BONE MARROW TRANSPLANTATION, 1999, 23 : S223 - S223
  • [27] Prophylactic Treatment of Hepatic Veno-occlusive Disease During Stem Cell Transplantation
    Button, Elise
    CANCER NURSING, 2016, 39 (04) : 335 - 336
  • [28] Comparison of Total Body Irradiation with Busulfan/Cyclophosphamide on the Development of Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation.
    Qiao, J.
    Zeng, L.
    Fang, T.
    Liu, M.
    Huang, Y.
    Xu, K.
    TRANSPLANTATION, 2014, 98 : 678 - 678
  • [29] The incidence and risk factors of hepatic veno-occlusive disease after hematopoietic stem cell transplantation in Taiwan
    Lee, Chien-Chang
    Chang, Hsiu-Hao
    Lu, Meng-Yao
    Yang, Yung-Li
    Chou, Shu-Wei
    Lin, Dong-Tsamn
    Jou, Shiann-Tarng
    Yao, Ming
    Li, Chi-Cheng
    Yeh, Su-Peng
    Chen, Mei-Hui
    Gau, Jyh-Pyng
    Li, Sin-Syue
    Wang, Po-Nan
    Liu, Yi-Chang
    Wang, Tso-Fu
    Tan, Tran-Der
    Lee, Ming-Yang
    Yu, Ming-Sun
    Wang, Chuan-Cheng
    Lin, Shih-Chiang
    Chen, Yeu-Chin
    Su, Yung-Cheng
    Su, Ko-Ying
    Lin, Kai-Hsin
    ANNALS OF HEMATOLOGY, 2019, 98 (03) : 745 - 752
  • [30] Hepatic veno-occlusive disease resulting in tacrolimus toxicity after allogeneic hematopoietic stem cell transplantation
    Shin, Seung-Hwan
    Yahng, Seung-Ah
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Kim, Yoo-Jin
    BLOOD RESEARCH, 2013, 48 (01) : 55 - 57
12345